CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Current Federal Tax Expense (Benefit)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Current Federal Tax Expense (Benefit) of $10.87 million for the 12-month period ending 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2026-02-18
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. current federal tax expense (benefit) for fiscal 2025 was $10.87M, a 70.09% decline from fiscal 2024.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. current federal tax expense (benefit) for fiscal 2024 was $36.35M, a 25.95% decline from fiscal 2023.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. current federal tax expense (benefit) for fiscal 2023 was $49.09M, a 34.59% decline from fiscal 2022.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. current federal tax expense (benefit) for fiscal 2022 was $75.05M, a 129.32% increase from fiscal 2021.
| Period end | Current Federal Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-27 | $10.87M 10-K · filed 2026-02-18 |
| 2024-12-28 | $36.35M 10-K · filed 2026-02-18 |
| 2023-12-30 | $49.09M 10-K · filed 2026-02-18 |
| 2022-12-31 | $75.05M 10-K · filed 2025-02-19 |
| 2021-12-25 | $32.73M 10-K · filed 2024-02-14 |
| 2020-12-26 | $38.19M 10-K · filed 2023-02-22 |
| 2019-12-28 | $18.10M 10-K · filed 2022-02-16 |
| 2018-12-29 | $17.39M 10-K · filed 2021-02-17 |
| 2017-12-30 | $93.87M 10-K · filed 2020-02-11 |
| 2016-12-31 | $18.59M 10-K · filed 2019-02-13 |
| 2015-12-26 | $23.69M 10-K · filed 2018-02-13 |
| 2014-12-27 | $13.73M 10-K · filed 2017-02-14 |
| 2013-12-28 | $10.83M 10-K · filed 2016-02-12 |
| 2012-12-29 | -$1.45M 10-K · filed 2015-02-17 |
| 2011-12-31 | $3.96M 10-K · filed 2014-02-25 |
| 2010-12-25 | $11.38M 10-K · filed 2013-02-27 |
| 2009-12-26 | -$4.61M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |